Svante Vikingsson

2.1k total citations
75 papers, 1.2k citations indexed

About

Svante Vikingsson is a scholar working on Toxicology, Pharmacology and Molecular Biology. According to data from OpenAlex, Svante Vikingsson has authored 75 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Toxicology, 21 papers in Pharmacology and 16 papers in Molecular Biology. Recurrent topics in Svante Vikingsson's work include Forensic Toxicology and Drug Analysis (40 papers), Cannabis and Cannabinoid Research (21 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Svante Vikingsson is often cited by papers focused on Forensic Toxicology and Drug Analysis (40 papers), Cannabis and Cannabinoid Research (21 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Svante Vikingsson collaborates with scholars based in Sweden, United States and United Kingdom. Svante Vikingsson's co-authors include Henrik Gréen, Robert Kronstrand, Shimpei Watanabe, Martin Josefsson, Ariane Wohlfarth, Markus Roman, Sven Almér, Curt Peterson, Björn Carlsson and Davide Guerrieri and has published in prestigious journals such as Genes & Development, Gastroenterology and PLoS ONE.

In The Last Decade

Svante Vikingsson

69 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Svante Vikingsson Sweden 21 548 413 329 198 172 75 1.2k
Jeffrey P. Walterscheid United States 19 217 0.4× 314 0.8× 135 0.4× 86 0.4× 76 0.4× 31 1.3k
Diane L. Phillips United States 17 106 0.2× 425 1.0× 180 0.5× 58 0.3× 58 0.3× 33 1.5k
Mario Thevis Germany 17 157 0.3× 313 0.8× 134 0.4× 47 0.2× 35 0.2× 47 1.2k
Brianna L. Peterson United States 13 146 0.3× 227 0.5× 108 0.3× 67 0.3× 17 0.1× 16 540
Suk Han Wan United States 14 71 0.1× 125 0.3× 125 0.4× 51 0.3× 196 1.1× 22 819
Werner Windischhofer Austria 21 89 0.2× 462 1.1× 145 0.4× 84 0.4× 25 0.1× 71 1.2k
Diethart Schmid Austria 19 45 0.1× 472 1.1× 54 0.2× 102 0.5× 180 1.0× 46 1.2k
Torsten Arndt Germany 18 99 0.2× 343 0.8× 75 0.2× 54 0.3× 16 0.1× 38 1.1k
Ernst‐Ulrich Griese Germany 19 41 0.1× 334 0.8× 216 0.7× 44 0.2× 40 0.2× 29 1.6k
Birgit L. Coffman United States 14 56 0.1× 852 2.1× 229 0.7× 50 0.3× 84 0.5× 21 1.8k

Countries citing papers authored by Svante Vikingsson

Since Specialization
Citations

This map shows the geographic impact of Svante Vikingsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svante Vikingsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svante Vikingsson more than expected).

Fields of papers citing papers by Svante Vikingsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svante Vikingsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svante Vikingsson. The network helps show where Svante Vikingsson may publish in the future.

Co-authorship network of co-authors of Svante Vikingsson

This figure shows the co-authorship network connecting the top 25 collaborators of Svante Vikingsson. A scholar is included among the top collaborators of Svante Vikingsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Svante Vikingsson. Svante Vikingsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grabenauer, Megan, et al.. (2024). Prevalence of opioid glucuronides in human hair. Forensic Chemistry. 39. 100578–100578.
2.
Grabenauer, Megan, et al.. (2024). Systematic web monitoring of drug test subversion strategies in the United States. Drug Testing and Analysis. 17(1). 34–41.
3.
Vikingsson, Svante, Ruth E. Winecker, Eugene D Hayes, et al.. (2024). Stability of Nano-Emulsified Cannabidiol in Acidic Foods and Beverages. Cannabis and Cannabinoid Research. 10(2). 213–219. 1 indexed citations
4.
Vikingsson, Svante, et al.. (2023). Conversion of water-soluble CBD to ∆9-THC in synthetic gastric fluid—An unlikely cause of positive drug tests. Journal of Analytical Toxicology. 47(7). 632–635. 2 indexed citations
5.
Vikingsson, Svante, et al.. (2023). ∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods. Journal of Analytical Toxicology. 47(7). 557–562. 5 indexed citations
6.
Bäckberg, Matilda, Svante Vikingsson, Joakim Strandberg, et al.. (2023). Using in vitro receptor activity studies of synthetic cannabinoids to support the risk assessment of new psychoactive substances – A Swedish strategy to protect public health from harm. Forensic Science International. 348. 111691–111691. 6 indexed citations
7.
Vikingsson, Svante, et al.. (2022). Metabolism studies of 4′Cl‐CUMYL‐PINACA, 4′F‐CUMYL‐5F‐PINACA and 4′F‐CUMYL‐5F‐PICA using human hepatocytes and LC‐QTOF‐MS analysis. Basic & Clinical Pharmacology & Toxicology. 132(3). 263–280. 6 indexed citations
8.
Vandeputte, Marthe M., Donna Walther, Svante Vikingsson, et al.. (2022). Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays. Archives of Toxicology. 96(3). 877–897. 18 indexed citations
9.
Vikingsson, Svante, et al.. (2020). The influence of ABCG2 polymorphism on erlotinib efflux in the K562 cell line. Pharmacology Research & Perspectives. 8(2). 6 indexed citations
10.
11.
Kronstrand, Robert, Davide Guerrieri, Svante Vikingsson, Ariane Wohlfarth, & Henrik Gréen. (2018). Fatal Poisonings Associated with New Psychoactive Substances. Handbook of experimental pharmacology. 252. 495–541. 42 indexed citations
12.
Vikingsson, Svante, Ariane Wohlfarth, Mikael Andersson, et al.. (2017). Identifying Metabolites of Meclonazepam by High-Resolution Mass Spectrometry Using Human Liver Microsomes, Hepatocytes, a Mouse Model, and Authentic Urine Samples. The AAPS Journal. 19(3). 736–742. 30 indexed citations
13.
Folkesson, Maggie, Svante Vikingsson, Matts Karlsson, et al.. (2016). Differences in cardiovascular toxicities associated with cigarette smoking and snuff use revealed using novel zebrafish models. Biology Open. 5(7). 970–978. 15 indexed citations
14.
15.
Gréen, Henrik, Ilya Kupershmidt, Daniel Edsgärd, et al.. (2015). Using Whole-Exome Sequencing to Identify Genetic Markers for Carboplatin and Gemcitabine-Induced Toxicities. Clinical Cancer Research. 22(2). 366–373. 20 indexed citations
16.
Skoglund, Karin, Johan Richter, Ulla Olsson‐Strömberg, et al.. (2015). In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid Leukemia. Therapeutic Drug Monitoring. 38(2). 230–238. 10 indexed citations
17.
18.
Skoglund, Karin, et al.. (2013). Single-nucleotide polymorphisms of ABCG2 increase the efficacy of tyrosine kinase inhibitors in the K562 chronic myeloid leukemia cell line. Pharmacogenetics and Genomics. 24(1). 52–61. 31 indexed citations
19.
Haglund, Sofie, Svante Vikingsson, Jan Söderman, et al.. (2011). The Role of Inosine-5′-Monophosphate Dehydrogenase in Thiopurine Metabolism in Patients With Inflammatory Bowel Disease. Therapeutic Drug Monitoring. 33(2). 200–208. 22 indexed citations
20.
Vikingsson, Svante, et al.. (2010). A validated and rapid high-performance liquid chromatography method for the quantification of conversion of radio-labelled sex steroids. Hormone Molecular Biology and Clinical Investigation. 3(1). 375–381. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey P. Walterscheid Breakdown of academic impact, for papers by Diane L. Phillips Breakdown of academic impact, for papers by Mario Thevis Breakdown of academic impact, for papers by Brianna L. Peterson Breakdown of academic impact, for papers by Suk Han Wan Breakdown of academic impact, for papers by Werner Windischhofer Breakdown of academic impact, for papers by Diethart Schmid Breakdown of academic impact, for papers by Torsten Arndt Breakdown of academic impact, for papers by Ernst‐Ulrich Griese Breakdown of academic impact, for papers by Birgit L. Coffman
Rankless by CCL
2026